期刊文献+

重组人脑利钠肽治疗急性心力衰竭的疗效观察 被引量:11

下载PDF
导出
摘要 目的观察重组人脑利钠肽治疗急性心力衰竭的临床疗效。方法将34例急性心力衰竭患者随机分为治疗组(16例)和对照组(18例)。两组患者均给予抗心力衰竭常规治疗,治疗组加用重组人脑利钠肽,首次静脉注射负荷剂量为1.5μg/kg,之后以0.007 5μg/(kg·min)剂量持续静脉泵泵入,连续用药72h。观察两组患者治疗前及治疗后3d的临床症状、心率、血压及左室射血分数(LVEF)等变化,并测定患者血浆氨基末端脑钠肽前体(NT-proBNP)浓度。结果治疗组显效率和总有效率均显著优于对照组(P<0.01)。两组治疗后3d心率、LVEF、NT-proBNP浓度均较治疗前明显改善(P<0.05),但治疗组改善程度优于对照组(P<0.05)。结论重组人脑利钠肽可以显著改善急性心力衰竭患者的临床症状和心功能,降低血浆中NT-proBNP的浓度。
出处 《中西医结合心脑血管病杂志》 2014年第6期690-691,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献8

  • 1Wayne L*John CK, Aren A,et al. Role for precursor Pro - B typenatriuretic peptide in assessing response to therapy and prognosisin patients with decompensated heart failure treated with nesiritide[J]. Clinica Chimica Acta,2009 ,406 : 119 - 123.
  • 2Cynthuia MB, Pasqualina S, Robert M,et al. Physiological, patho-logical . pharmacological, biochemical and hematologica factors af-fecting BNP and NT - proBNP[J]. Clinical Biochemistry, 2008.41.4/5):231 -239.
  • 3刘思泰,蒋涛,冉斌,李德才,云红梅,李海洋,张大勇.新活素治疗充血性心力衰竭48例临床观察[J].四川医学,2009,30(5):711-712. 被引量:42
  • 4葛均波,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:21.
  • 5朱妙章,唐朝枢,朱大年,等.心血管生理学基础与临床[M].北京:高等教育出版社,2011:241-246.
  • 6周志明,周玉杰,谢英,史冬梅,梁静.重组人脑利钠肽治疗失代偿性心力衰竭的临床观察[J].心肺血管病杂志,2008,27(5):261-263. 被引量:26
  • 7Tanner H,Mohacsi P,Fuller - Bicer GA,et al. Cytokine activationand disease progression in patients with stable moderate chronicheart failure[J].J Heart Lung Transplant,2007,26 :622 - 629.
  • 8Kawakami R,Saito Y*Kishimoto \,et al. Over expression of brainnatriuretic peptide facilitates neutrophil infiltration and cardiac ma-trix metallo proteinase 29 expression after acute myocardial infarc-tion[J]. Circulation,2004,110(21) :3306 -3312.

二级参考文献15

  • 1蒋涛,李德才,刘思泰,唐焕君,李健,凌云.1998,2001和2004年绵阳市慢性心力衰竭住院患者药物治疗动态分析[J].四川医学,2006,27(6):598-600. 被引量:19
  • 2蒋涛,李德才,刘思泰,唐焕君,李健,凌云.2038例慢性心力衰竭住院患者药物治疗动态分析[J].中国现代医学杂志,2007,17(1):76-79. 被引量:20
  • 3braham WT,Kowes BD,Fergusan DA,et al.Systemic hemodynanmic,neurohonnenal,and renal excretory effects of a steady state infusion of human brain natriuretic peptide in patient with decompensated chronic heart failure[J].J Card Fail,1998,4(1):37 - 44
  • 4Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarctien[J].Circulation,2004,,110(21):3306-3312
  • 5Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure[J].Drugs,2003,63(1):47-70
  • 6Strain WD.The use of recombinant human B-type natriutetic peptide(nesiritide) in the management,of acute decompensated heat failunre[J].Int J Clin Pract,2004,58(11):1081-1087
  • 7Gordon W Moe,Jonathan Howlett,James L.Response to letter regarding articly,“N-terminal Pro-B-type natriuretic peptide testing improves the mangement of patients with suspected acute heart failure:primary results of the canadian prospective randomized muhicenter IMPROVE-CHF study”[J].Cirulation,2008,117(1):6
  • 8Cohcei WS.Nesiritide for the treatment of decompensated heart failure[J].J Cant Fail,2001,7(1):92- 100
  • 9Jack F Price,Anne K,et al.B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction[J].Circtdatiou,2006,114(10):1063-1069
  • 10Khawaja Afzal Ammar,Steven J,Jacobsen,et al.Prevalence and prognostic significance of heart failure stages:application of the American college of cardiology/American heart association heart failure staging criteria in,the community[J].Cirulation,2007,115(12):1563 - 1570

共引文献324

同被引文献83

引证文献11

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部